The upstream bioprocessing market is experiencing unprecedented growth, with projections indicating a surge from USD 24.16 billion in 2023 to an astounding USD 105.30 billion by 2034. This remarkable expansion is driven by several key factors, including the rising demand for biopharmaceuticals,
The development of synthetic intramembrane proteolysis receptors (SNIPRs) engineered by researchers in the United States could be a game-changer for CAR T-cell cancer therapies. This groundbreaking advancement introduces a novel methodology to enhance the precision and safety of CAR T-cell
Recent advancements in medical technologies have often led to breakthroughs that were once considered unattainable, and the field of orthopedic surgery is no exception. Researchers from Cincinnati Children’s Hospital and the University of Cincinnati (UC) have developed an innovative 3D-printed
Biopharmaceutical fermentation systems are at the forefront of modern medicine, playing a crucial role in the production of biological drugs such as therapeutic proteins, enzymes, monoclonal antibodies, and vaccines. These systems are designed to cultivate microorganisms or cells in controlled
RTI Surgical recently unveiled a $15 million expansion of its Class III medical device facility in Alachua, Florida, marking a significant milestone in its commitment to advancing tissue engineering. This extensive overhaul includes the addition of a 5,000 square-foot clean room, drastically
Quantum dots, the nanoscale semiconductor particles that exhibit quantum mechanical phenomena, have emerged as a revolutionary tool in biotechnology. Due to their unique optical and electronic properties, quantum dots are being integrated into various applications, enhancing the capabilities of
